Drugmaker Sanofi to raise over $11 billion via sale of Regeneron shares

Sanofi will raise over $11 billion from the sale of 21.6 million shares in its U.S. partner Regeneron , the French drugmaker said on Wednesday, adding it would use the proceeds for innovation and general growth.